Slco6d1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the solute carrier organic anion transporter family member 6D1 (Slco6d1). Slco6d1 belongs to the larger family of solute carrier (SLC) transporters, which are membrane proteins responsible for the transport of organic anions and various molecules across cellular membranes. These transporters play a critical role in maintaining cellular homeostasis by facilitating the movement of ions and organic substrates in and out of cells. Inhibitors of Slco6d1 work by binding to specific regions of the transporter, preventing the proper translocation of its substrates across the membrane. This interference can disrupt the normal cellular processes that depend on the transport of specific molecules mediated by Slco6d1.
The design and development of Slco6d1 inhibitors involve a detailed understanding of the protein's structure and function. Researchers rely on structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, to identify potential binding sites on Slco6d1 where inhibitors can attach. By studying the protein's conformation and its interactions with substrates, scientists can design inhibitors that block its activity without interfering with other similar transporters. These inhibitors are tested through various biochemical assays to determine their binding affinity, specificity, and ability to inhibit Slco6d1's transport function. The study of Slco6d1 inhibitors contributes to a broader understanding of solute carrier transporters and their role in cellular physiology. By selectively modulating the function of Slco6d1, researchers can explore its specific biological role and the impact of its inhibition on cellular transport mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
An antibiotic known to induce the expression of several SLCO transporters, potentially altering SLCO6D1 activity indirectly. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant that inhibits multiple SLCO transporters, possibly affecting SLCO6D1 by altering substrate competition. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
A lipid-lowering drug that interacts with various SLCO transporters, potentially influencing SLCO6D1 activity through modulation of lipid metabolism. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
A statin that is a substrate for several SLCO transporters, potentially affecting SLCO6D1 by altering transporter availability or specificity. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
A nonsteroidal anti-inflammatory drug (NSAID) known to interact with SLCO transporters, which could extend to SLCO6D1, influencing its transport efficiency. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $27.00 $38.00 $98.00 $272.00 | 28 | |
It can inhibit the function of several SLCO transporters, possibly affecting SLCO6D1 by modulating competition for anionic substrates. | ||||||
Silymarin group, mixture of isomers | 65666-07-1 | sc-301806 | 50 g | $319.00 | ||
A mixture of flavonolignans from milk thistle thought to affect SLCO transporter activity, potentially modulating SLCO6D1 indirectly. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
An antifungal agent shown to inhibit several SLCO transporters, which might include SLCO6D1, affecting its function. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
An antibiotic that interacts with SLCO transporters, potentially modulating SLCO6D1 activity through competition or inhibition. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
An antiretroviral drug reported to inhibit SLCO transporter activity, which could affect SLCO6D1 indirectly. |